Publications by authors named "Fernando Canas"

Claim this Profile
D
Deciphering the Tangible Spatio-Temporal Spread of a 25-Year Tuberculosis Outbreak Boosted by Social Determinants.
Mariana G López, Ma Isolina Campos-Herrero, Manuela Torres-Puente, Fernando Cañas, Jessica Comín

Microbiol Spectr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain.
Celso Arango, Inmaculada Baeza, Miquel Bernardo, Fernando Cañas, Consuelo de Dios

Rev Psiquiatr Salud Ment (Engl Ed)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mycobacterium tuberculosis Beijing strain persists at high rates and extends its geographic boundaries 20 years after importation.
Laura Pérez-Lago, María Isolina Campos-Herrero, Fernando Cañas, Rodolfo Copado, Laura Sante

Sci Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.
Miguel Bernardo, Fernando Cañas, Berta Herrera, Marta García Dorado

Rev Psiquiatr Salud Ment· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey.
Robin Emsley, Koksal Alptekin, Jean-Michel Azorin, Fernando Cañas, Vincent Dubois

Ther Adv Psychopharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a pragmatic and operational definition of relapse in schizophrenia: A Delphi consensus approach.
Luis San, Manuel Serrano, Fernando Cañas, Samuel Leopoldo Romero, Ángeles Sánchez-Cabezudo

Int J Psychiatry Clin Pract· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to first-line antituberculosis drugs in Spain, 2010-2011. RETUBES Study.
Rafael Blanquer, Teresa Rodrigo, Martí Casals, Juan Ruiz Manzano, José María García-García

Arch Bronconeumol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment adherence and quality of sleep in schizophrenia outpatients.
Pedro Afonso, Sofia Brissos, Fernando Cañas, Julio Bobes, Ivan Bernardo-Fernandez

Int J Psychiatry Clin Pract· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfaction with Life of Schizophrenia Outpatients and Their Caregivers: Differences between Patients with and without Self-Reported Sleep Complaints.
Sofia Brissos, Pedro Afonso, Fernando Cañas, Julio Bobes, Ivan Bernardo Fernandez

Schizophr Res Treatment· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving treatment adherence in your patients with schizophrenia: the STAY initiative.
Fernando Cañas, Koksal Alptekin, Jean Michel Azorin, Vincent Dubois, Robin Emsley

Clin Drug Investig· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.
José Manuel Olivares, Köksal Alptekin, Jean-Michel Azorin, Fernando Cañas, Vincent Dubois

Patient Prefer Adherence· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid test for identification of a highly transmissible Mycobacterium tuberculosis Beijing strain of sub-Saharan origin.
María Isabel Millán-Lou, Henar Alonso, Patricia Gavín, Melissa Hernández-Febles, María Isolina Campos-Herrero

J Clin Microbiol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.
Fernando Cañas, Christoph U Correll, Andrea Fagiolini, Ilkka Larmo, Pedro Levy

Expert Opin Pharmacother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
Alessandro Rossi, Fernando Cañas, Andrea Fagiolini, Ilkka Larmo, Pedro Levy

Postgrad Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for successful clinical management of schizophrenia with ziprasidone.
Andrea Fagiolini, Fernando Cañas, Bernd Gallhofer, Ilkka Larmo, Pedro Levy

Expert Opin Pharmacother· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review.
Fernando Cañas, Hans-Jürgen Möller

Expert Opin Drug Saf· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study.
José Ramón Gutiérrez-Casares, Fernando Cañas, Alexander Rodríguez-Morales, Rebeca Hidalgo-Borrajo, David Alonso-Escolano

CNS Spectr· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
Victor Perez, Fernando Cañas, Monica Tafalla,

Int Clin Psychopharmacol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trial.
Fernando Cañas, Víctor Pérez-Solá, Silvia Díaz, Javier Rejas,

Clin Drug Investig· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of agitation in the acute psychotic patient--efficacy without excessive sedation.
Fernando Cañas

Eur Neuropsychopharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of olanzapine in monotherapy: a multivariate analysis of a naturalistic study.
Antonio Ciudad, Miguel Gutiérrez, Fernando Cañas, Juan Gibert, Josep Gascón

Prog Neuropsychopharmacol Biol Psychiatry· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, effectiveness, and patterns of use of olanzapine in acute schizophrenia: a multivariate analysis of a large naturalistic study in the hospital setting.
Fernando Cañas, Antonio Ciudad, Miguel Gutiérrez, Juan Gibert, Josep Gascón

Med Clin (Barc)· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
Julio Bobes, Fernando Cañas, Javier Rejas, Joan Mackell

Prog Neuropsychopharmacol Biol Psychiatry· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients.
Julio Bobes, Juan Gibert, Antonio Ciudad, Enrique Alvarez, Fernando Cañas

Prog Neuropsychopharmacol Biol Psychiatry· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.
Enrique Alvarez, Julio Bobes, Juan-Carlos Gómez, José Antonio Sacristán, Fernando Cañas

Eur Neuropsychopharmacol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis